Artemis Electricals IPO vs Par Drugs IPO

Comparison between Artemis Electricals IPO and Par Drugs IPO.

IPO Details

Artemis Electricals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Artemis Electricals IPO is up to ₹39.86 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Artemis Electricals IPO is ₹60.00 per share and of Par Drugs IPO is ₹51.00 per share.

 Artemis Electricals IPOPar Drugs IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹54.00 per share
Issue Price (Upper)₹60.00 per share
Issue Price (Final)₹60.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size2000 shares2000 shares
Fresh Issue Size66,44,000 shares15,88,000 shares
Fresh Issue Size (Amount)up to ₹39.86 Crup to ₹8.10 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total66,44,000 shares15,88,000 shares
Issue Size Total (Amount)up to ₹39.86 Crup to ₹8.10 Cr

IPO Timetable

Artemis Electricals IPO opens on Apr 24, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Artemis Electricals IPO and Par Drugs IPO is May 06, 2019, and May 08, 2019, respectively.

 Artemis Electricals IPOPar Drugs IPO
Issue OpenApr 24, 2019May 03, 2019
Issue CloseMay 06, 2019May 08, 2019
Basis Of Allotment (Tentative)May 06, 2019May 13, 2019
Initiation of Refunds (Tentative)May 08, 2019May 14, 2019
Credit of Share (Tentative)May 10, 2019May 15, 2019
Listing date (Tentative)May 14, 2019May 16, 2019

Financials & KPIs

Artemis Electricals IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .

 Artemis Electricals IPOPar Drugs IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Oct 201831 Mar 201831 Mar 201731 Mar 2016
Assets64.8567.3319.6913.79
Total Income52.4289.5147.2445.34
Profit After Tax5.939.531.771.55
EBITDA9.7315.033.102.46
NET Worth23.9017.978.446.67
Reserves and Surplus10.5913.544.012.24
Total Borrowing11.3812.280.420.35
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)91.58%99.55%
Promoter Shareholding (Post-Issue)65.63%72.5%
Market Cap₹148.22 Cr.₹31.38 Cr.

Shares Offered

In the Artemis Electricals IPO Retail Individual Investors (RII) are offered 33,22,000 shares while in Par Drugs IPO retail investors are offered 33,22,000 shares. Qualified Institutional Buyers (QIB) are offered in Artemis Electricals IPO and in Par Drugs IPO.

 Artemis Electricals IPOPar Drugs IPO
Market Maker Reservation3,56,000 shares84,000 shares
NII33,22,000 shares7,78,000 shares
RII33,22,000 shares7,80,000 shares
Employee30,000 shares
Total66,44,000 shares15,88,000 shares

Bids Received (Subscription)

Artemis Electricals IPO subscribed 1.06x in total, whereas Par Drugs IPO subscribed 5.64x.

 Artemis Electricals IPOPar Drugs IPO
NII (times)1.67x3.48x
RII (times)0.45x7.97x
Employee (times)1.00x
Total (times)1.06x5.64x

Compare with others

Compare:

Artemis Electricals IPO Vs Par Drugs IPO